Aethon Therapeutics
Latest round
- Series A
Last raised
- Dec 2022
Total raised
- $6M
Investors
- 2
About Aethon Therapeutics
Based in New York, US, and founded in 2022 by Raj Chopra (CEO), and Paul Da Silva Jardine, Aethon Therapeutics, Inc. operates as a biotechnology company that creates antibodies that are tailored to work with targeted medicines to specifically attack cancer cells that have developed drug resistance. In January 2023, Aethon Therapeutics, Inc. Aethon Therapeutics, Inc. is a platform that is aimed at bridging the gap between targeted and immune therapy. The company provides products such as antibodies that are designed to be used in connection with targeted therapies to preferentially kill drug-resistant cancer cells, and provide health professionals with neoantigens by design that combine immunotherapy and targeted therapy to expand the power and promise of both approaches for cancer patients.
Who invested in Aethon Therapeutics
2 investors across 1 round
See all investors in Aethon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 16, 2022
Amount
$6M
Investors
Questions about Aethon Therapeutics
Who invested in Aethon Therapeutics?
Aethon Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aethon Therapeutics raised?
Aethon Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aethon Therapeutics last raise money?
Aethon Therapeutics's most recent round on record is a Series A, in Dec 2022.
What does Aethon Therapeutics do?
Based in New York, US, and founded in 2022 by Raj Chopra (CEO), and Paul Da Silva Jardine, Aethon Therapeutics, Inc.
Where is Aethon Therapeutics headquartered?
Aethon Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Aethon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aethon Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Aethon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.